Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment response in Paget's disease.

Literature DB >> 7492213

Treatment response in Paget's disease.

S Patel¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1995 PMID： 7492213 PMCID： PMC1010006 DOI： 10.1136/ard.54.10.783

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

16 in total

1. Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.

Authors: A J Fenton; D H Gutteridge; G N Kent; R I Price; R W Retallack; C I Bhagat; G K Worth; R I Thompson; I G Watson; C Barry-Walsh
Journal: Clin Endocrinol (Oxf) Date: 1991-03 Impact factor: 3.478

Review 2. Advances in the management of Paget's disease of bone.

Authors: D J Hosking
Journal: Drugs Date: 1990-12 Impact factor: 9.546

3. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.

Authors: R E Gray; A J Yates; C J Preston; R Smith; R G Russell; J A Kanis
Journal: Q J Med Date: 1987-09

4. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

Authors: A J Yates; R C Percival; R E Gray; R M Atkins; G H Urwin; N A Hamdy; C J Preston; M N Beneton; R G Russell; J A Kanis
Journal: Lancet Date: 1985-06-29 Impact factor: 79.321

5. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Authors: S Adami; M Mian; P Gatti; M Rossini; N Zamberlan; F Bertoldo; V Lo Cascio
Journal: Bone Date: 1994 Jul-Aug Impact factor: 4.398

6. Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.

Authors: U Patel; S J Gallacher; I T Boyle; J H McKillop
Journal: Nucl Med Commun Date: 1990-11 Impact factor: 1.690

Treatment response in Paget's disease.

1. Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.

Review 2. Advances in the management of Paget's disease of bone.

3. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.

4. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

5. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

6. Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.

7. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.

8. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.

Review 9. Long-term follow-up observations on treatment in Paget's disease of bone.

10. Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed.

Review 1. Treatment of patients with Paget's disease of bone.